Biosimilar Hormones Global Market Report 2024 - Niche Sectors Record Notable Market Contributions
Wednesday, February 21, 2024
DUBLIN, Feb. 13, 2024 /PRNewswire/ -- The "Biosimilar Hormones Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The biosimilar hormones market has witnessed an impressive growth trajectory and is projected to advance robustly in the coming years. Surging demand and significant developments in healthcare have led to this expanding market, which shows no signs of slowing down. A comprehensive analysis detailing these findings has been released, presenting in-depth insights into the global biosimilar hormones market.
Escalating Prevalence of Chronic Diseases Boost Biosimilars Uptake
The global biosimilar hormones market has experienced exponential growth and is forecasted to continue this ascent. Recent healthcare trends, including the rise of chronic disease prevalence and an aging population in need of hormone-related treatments, are some of the pivotal drivers propelling the market forward.
Market size figures speak volumes, with the industry poised to burgeon from a sizable $3.9 billion in 2023 to an estimated $4.98 billion in 2024, exhibiting a remarkable compound annual growth rate (CAGR) of 27.5%. Looking further ahead, the market is expected to soar, reaching $11.77 billion by 2028, at a CAGR of 24.0%. These numbers reflect the booming demand and ever-increasing embrace of biosimilar hormones.
Niche Sectors Record Notable Market Contributions
A noteworthy segment within the biosimilar hormones domain is the market for insulin biosimilars. With diabetes incidence on the rise globally, this segment is expected to contribute significantly to market growth. Estimates suggest that the global diabetic population could escalate to 643 million by 2030, underscoring the vast potential for biosimilar hormones in diabetes management.
Strategic Developments Fuel Market Expansion
Recent strategic collaborations have been pivotal in driving market growth, with industry leaders seeking to capitalize on untapped regional markets. For instance, a significant partnership has been struck targeting the development of biosimilar medicines specifically for the Japanese market.
Moreover, product approvals, such as the FDA's recent nod to a once-weekly growth hormone therapy for children with growth hormone deficiency, underscore the relentless innovation and sharp competitive edge within the biosimilar hormones industry.
-- North America Dominates the Biosimilar Hormones Market
-- New Product Launches Catalyze Market Growth
-- Diabetes Management Emerges as a Significant Market Stimulant
With growth hormone deficiencies and diabetes as perennial concerns in global health, biosimilar hormones stand as vital components in treatment protocols. Their role is further amplified by the convenience of multiple distribution channels, including e-pharmacy platforms that enhance accessibility.
The comprehensive market research report reveals the global and regional market dynamics, covering market size, share, trends, and opportunities. It also delves into the competitive landscape, providing invaluable guidance to stakeholders, investors, and healthcare providers aiming to navigate the biosimilar hormones market with strategic acumen and foresight.
Market Applications Span Across Healthcare Spectrum
Biosimilar hormones are being used extensively across various fields, from therapeutic applications to research and diagnostics. This diversity in application underscores the pivotal role of biosimilar hormones in advancing multiple aspects of healthcare.
This in-depth market research provides a holistic view of the biosimilar hormones landscape, reflecting the industry's current state and foreshadowing its future trajectory.
Report Scope
-- The market characteristics section of the report defines and explains
the market.
-- The market size section gives the market size ($b) covering both the
historic growth of the market, and forecasting its development.
-- The forecasts are made after considering the major factors currently
impacting the market. These include:
-- The impact of sanctions, supply chain disruptions, and altered demand
for goods and services due to the Russian Ukraine war, impacting various
macro-economic factors and parameters in the Eastern European region and
its subsequent effect on global markets.
-- The impact of higher inflation in many countries and the resulting spike
in interest rates.
-- Market segmentations break down the market into sub markets.
-- The regional and country breakdowns section gives an analysis of the
market in each geography and the size of the market by geography and
compares their historic and forecast growth.
-- The competitive landscape chapter gives a description of the competitive
nature of the market, market shares, and a description of the leading
companies. Key financial deals which have shaped the market in recent
years are identified.
-- The trends and strategies section analyses the shape of the market as it
emerges from the crisis and suggests how companies can grow as the
market recovers.
Companies Profiled
-- Teva Pharmaceutical Industries Ltd.
-- Gedeon Richter Plc.
-- Intas Pharmaceuticals Ltd.
-- Biocon Limited
-- Mylan
-- Sanofi
-- Sandoz (Novartis)
-- LG Life Sciences
-- Ferring Pharmaceuticals
-- GC Pharma
-- Pfizer Inc.
-- Dr. Reddy's Laboratories
-- Amgen Inc.
-- Eli Lilly and Company
-- Celltrion Inc.
-- Samsungbioepis Co.Ltd
-- Merck & Co.
-- Biogen Inc.
-- Boehringer Ingelheim
-- Coherus BioSciences Inc.
-- Alvotech
-- BioXpress Therapeutics
-- Cipla Limited
-- Lupin Ltd.
-- Stada Arzneimittel AG
-- Torrent Pharmaceuticals
-- Zydus Cadila
-- Accord Healthcare
-- Hetero Drugs
-- Wockhardt
For more information about this report visit https://www.researchandmarkets.com/r/77pvkp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/biosimilar-hormones-global-market-report-2024---niche-sectors-record-notable-market-contributions-302060929.html
SOURCE Research and Markets
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
|
